英文别名 |
Ethyl 7-bromoheptanoate;7-Bromoheptanoic acid ethyl ester;7-Brom-heptansaeure-aethylester;BrCH2(CH2)5CO2Et;ethyl 7-bromanylheptanoate;ethyl 7-bromo-heptanoate;ethyl-4-bromoheptanoate;OOBFNDGMAGSNKA-UHFFFAOYSA;ETHYL-7-BROMOHEPTANOATE;Heptanoic acid, 7-bromo-, ethyl ester;M5QR4GAP1S;Ethyl7-Bromoheptanoate;Br(CH2)6COOEt;OOBFNDGMAGSNKA-UHFFFAOYSA-;OOBFNDGMAGSNKA-UHFFFAOYSA-N;7-bromo-heptanoic acid ethyl ester;Z;UNII-M5QR4GAP1S;F11933;EN300-152893;Tianeptine impurity A, European Pharmacopoeia (EP) Reference Standard;DTXSID80183961;EC 249-883-6;HY-W008245;TIANEPTINE SODIUM IMPURITY A [EP IMPURITY];29823-18-5;InChI=1/C9H17BrO2/c1-2-12-9(11)7-5-3-4-6-8-10/h2-8H2,1H3;SY009331;CS-W008245;W-110766;C9H17BrO2;FT-0621368;NS00004722;A820066;EINECS 249-883-6;B1880;BCP15664;Tianeptine Sodium Imp. A (EP); Tianeptine Imp. A (EP); 7-Bromoheptanoic acid ethyl ester; Ethyl 7-bromoheptanoate; Tianeptine Sodium Impurity A; Tianeptine Impurity A;STR06903;AI3-36604;Tianeptine impurity A;Ethyl 7-bromoheptanoate, 97%;SCHEMBL318062;MFCD00037103;AKOS015836154;DB-047657;TIANEPTINE SODIUM IMPURITY A (EP IMPURITY);BBL100353;DTXCID20106452;STL554146 |